Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-09-11
2000-04-04
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514247, 514350, 514351, 514344, 514352, 514355, 514357, 546296, 546297, 546298, 546301, 546302, 546309, 546312, 546339, A61K21322, C07D 3144
Patent
active
060462175
ABSTRACT:
The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
REFERENCES:
patent: 5480568 (1996-01-01), Pawloski et al.
patent: 5593994 (1997-01-01), Batt et al.
patent: 5686470 (1997-11-01), Weier
patent: 5861419 (1999-01-01), Dube et al.
Deschenes Denis
Dube Daniel
Fortin Rejean
Friesen Richard
Billups Richard C.
Davis Zinna Northington
Merck Frosst Canada & Co.
Rose David L.
LandOfFree
2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-365647